Serum Hyaluronan as a Disease Marker

作者: Torvard C. Laurent , Ulla B. G. Laurent , J.Robert E. Fraser

DOI: 10.3109/07853899609033126

关键词:

摘要: Hyaluronan is a connective tissue polysaccharide which has also been found in blood serum concentrations < 100 micrograms/L (average 30-40 middle-aged persons). The level regulated by the influx of from tissues via lymph and its receptor-mediated clearance liver endothelial cells. Markedly high levels are noted certain diseases, especially patients with cirrhosis, when impaired. In these cases hyaluronan can be used to follow development disease. Serum sensitive marker for impending rejection transplants. Patients rheumatoid arthritis constitute another major group increased hyaluronan, but this case varies markedly during day corresponding physical activity. There good indications that subjects excess comes joints. Under stringent sampling conditions it should possible extract interesting information on inflammatory joint process. Increased seen other diseases special interest septic sign poor prognosis. Certain tumours, notably Wilms' tumour mesothelioma, produce factors activate synthesis increase level. Rare hereditary disturbances metabolism elevated have discovered, e.g. Werner's syndrome cutaneous hyaluronanosis. Information accumulated last decade regarding made an clinical number pathological conditions.

参考文章(148)
H. LEVKSQUE, N. BAUDOT, B. DELPECH, M. VAYSSAIRAT, A. GANCEL, PH. LAURET, H. COURTOIS, Clinical correlations and prognosis based on hyaluronic acid serum levels in patients with progressive systemic sclerosis. British Journal of Dermatology. ,vol. 124, pp. 423- 428 ,(1991) , 10.1111/J.1365-2133.1991.TB00619.X
H. LEVESQUE, B. DELPECH, X. LE LOET, P. DESHAYES, SERUM HYALURONATE IN RHEUMATOID ARTHRITIS: STUDY BY AFFINO-IMMUNOENZYMATIC ASSAY Rheumatology. ,vol. 27, pp. 445- 449 ,(1988) , 10.1093/RHEUMATOLOGY/27.6.445
Jens H. Henriksen, Kirsten D. Bentsen, Torvard C. Laurent, Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease Journal of Hepatology. ,vol. 6, pp. 158- 166 ,(1988) , 10.1016/S0168-8278(88)80027-8
Bertrand Delpech, Bernard Chevallier, Nadine Reinhardt, Jean-Pierre Julien, Christian Duval, Catherine Maingonnat, Philippe Bastit, Bernard Asselain, Serum hyaluronan (hyaluronic acid) in breast cancer patients International Journal of Cancer. ,vol. 46, pp. 388- 390 ,(1990) , 10.1002/IJC.2910460309
Jacques Van Snick, Interleukin-6: An Overview Annual Review of Immunology. ,vol. 8, pp. 253- 278 ,(1990) , 10.1146/ANNUREV.IY.08.040190.001345
Daniel-Henri Manicourt, Rafak Triki, Kanji Fukuda, Jean-Pierre Devogelaer, Charles Nagant De Deuxchaisnes, Eugene J.-M. A. Thonar, Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis & Rheumatism. ,vol. 36, pp. 490- 499 ,(1993) , 10.1002/ART.1780360409
J. Kropf, Elisabeth Grobe, M. Knoch, M. Lammers, A. M. Gressner, H. Lennartz, The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal. Clinical Chemistry and Laboratory Medicine. ,vol. 29, pp. 805- 812 ,(1991) , 10.1515/CCLM.1991.29.12.805
A. LUNDIN, A. ENGSTROM-LAURENT, R. HALLGREN, G. MICHAELSSON, Circulating hyaluronate in psoriasis British Journal of Dermatology. ,vol. 112, pp. 663- 671 ,(1985) , 10.1111/J.1365-2133.1985.TB02334.X
J R Fraser, W G Kimpton, T C Laurent, R N P Cahill, N Vakakis, Uptake and degradation of hyaluronan in lymphatic tissue. Biochemical Journal. ,vol. 256, pp. 153- 158 ,(1988) , 10.1042/BJ2560153
Mohammed Sharif, Emmanuel George, Lee Shepstone, Warren Knudson, EUGENE J.-M. A. Thonar, Janet Cushnaghan, Paul Dieppe, Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee Arthritis & Rheumatism. ,vol. 38, pp. 760- 767 ,(1995) , 10.1002/ART.1780380608